Aura Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Aura Biosciences
AURA Stock  USD 5.57  0.06  1.09%   
Aura Biosciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Aura Biosciences' valuation are provided below:
Market Capitalization
349.9 M
Earnings Share
(1.91)
We have found one hundred twenty available fundamental signals for Aura Biosciences, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Aura Biosciences prevailing market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. The current year's Market Cap is expected to grow to about 490.1 M, whereas Enterprise Value is forecasted to decline to about 424.7 M.
Check Aura Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aura Biosciences' main balance sheet or income statement drivers, such as Net Interest Income of 11.4 M, Depreciation And Amortization of 1.1 M or Interest Expense of 1 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.93. Aura financial statements analysis is a perfect complement when working with Aura Biosciences Valuation or Volatility modules.
  
Build AI portfolio with Aura Stock
Check out the analysis of Aura Biosciences Correlation against competitors.
For information on how to trade Aura Stock refer to our How to Trade Aura Stock guide.

Aura Biosciences Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets161.5 M209.9 M93.3 M
Slightly volatile
Short and Long Term Debt Total11 M21.6 M5.5 M
Slightly volatile
Other Current Liabilities5.9 M10.9 M4.9 M
Slightly volatile
Total Current Liabilities9.9 M17.1 M8 M
Slightly volatile
Total Stockholder Equity142.2 M174.8 M80.6 M
Slightly volatile
Other Liabilities68.8 K74.7 K88.6 K
Slightly volatile
Property Plant And Equipment Net15 M23.7 M9 M
Slightly volatile
Accounts Payable2.3 M2.6 M2.3 M
Very volatile
Cash72.1 M36.4 M46.7 M
Slightly volatile
Non Current Assets Total15.8 M25.2 M9.4 M
Slightly volatile
Non Currrent Assets Other1.6 M1.5 M409.9 K
Slightly volatile
Other Assets1.091.15125.9 K
Pretty Stable
Long Term Debt39.2 K44.1 K48.1 K
Slightly volatile
Cash And Short Term Investments140.2 M173.8 M80.7 M
Slightly volatile
Common Stock Shares Outstanding42.5 M44.7 M1.7 B
Slightly volatile
Liabilities And Stockholders Equity161.5 M209.9 M93.3 M
Slightly volatile
Non Current Liabilities Total9.3 M18 M4.7 M
Slightly volatile
Other Current Assets11.5 M11 M3.5 M
Slightly volatile
Other Stockholder Equity323.6 M604.8 M162.3 M
Slightly volatile
Total Liabilities19.2 M35.1 M12.7 M
Slightly volatile
Property Plant And Equipment Gross17.8 M30.6 M11.3 M
Slightly volatile
Total Current Assets145.7 M184.7 M83.8 M
Slightly volatile
Net Working Capital135.8 M167.6 M75.8 M
Slightly volatile
Property Plant Equipment4.9 M6.2 M4.3 M
Slightly volatile
Current Deferred Revenue3.1 M4.4 M2.5 M
Slightly volatile
Short and Long Term Debt12 K13.5 K14.7 K
Slightly volatile
Short Term Debt2.1 M3.6 M898.5 K
Slightly volatile
Capital Surpluse391.1 M467.5 M337.2 M
Slightly volatile
Non Current Liabilities Other21.6 M20.6 M6 M
Slightly volatile

Aura Biosciences Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization1.1 M1.4 M760.5 K
Slightly volatile
Interest Expense1 M977.5 K271.8 K
Slightly volatile
Selling General Administrative14.6 M26.2 M9.5 M
Slightly volatile
Other Operating Expenses59.2 M110.5 M41.8 M
Slightly volatile
Research Development44.3 M84.3 M31.9 M
Slightly volatile
Cost Of Revenue1.1 M1.4 M760.8 K
Slightly volatile
Total Operating Expenses58.9 M110.5 M41.4 M
Slightly volatile
Reconciled Depreciation1.1 M1.4 M760.5 K
Slightly volatile
Interest Income11.4 M10.8 M2.4 M
Slightly volatile
Selling And Marketing Expenses15.8 M17.8 M19.4 M
Slightly volatile

Aura Biosciences Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation14.2 M13.5 M3.7 M
Slightly volatile
Begin Period Cash Flow69.5 M48.1 M37.5 M
Slightly volatile
Other Cashflows From Financing Activities1.7 M1.8 M40.1 M
Pretty Stable
Depreciation1.1 M1.4 M760.5 K
Slightly volatile
Dividends Paid31.8 M35.8 M39.1 M
Slightly volatile
Capital Expenditures1.1 M1.1 M1.8 M
Slightly volatile
Total Cash From Financing Activities1.7 M1.8 M45.4 M
Very volatile
End Period Cash Flow72.6 M37.3 M47 M
Slightly volatile
Change To Netincome7.4 M7 M2.4 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
PTB Ratio2.933.09829
Slightly volatile
Book Value Per Share2.822.751.5792
Slightly volatile
Capex To Depreciation1.891.183.0995
Slightly volatile
PB Ratio2.933.09829
Slightly volatile
Payables Turnover0.380.650.4021
Slightly volatile
Cash Per Share2.772.741.5516
Slightly volatile
Days Payables Outstanding5505791.2 K
Slightly volatile
Income Quality1.021.060.901
Slightly volatile
Net Debt To EBITDA0.150.161.2476
Slightly volatile
Current Ratio10.889.698.8813
Slightly volatile
Tangible Book Value Per Share2.822.751.5792
Slightly volatile
Shareholders Equity Per Share2.822.751.5792
Slightly volatile
Debt To Equity0.120.110.0335
Slightly volatile
Capex Per Share0.02390.02270.0137
Slightly volatile
Graham Net Net2.422.191.3411
Slightly volatile
Interest Debt Per Share0.220.340.1272
Slightly volatile
Debt To Assets0.09720.09260.0284
Slightly volatile
Price Book Value Ratio2.933.09829
Slightly volatile
Days Of Payables Outstanding5505791.2 K
Slightly volatile
Ebt Per Ebit1.061.040.9941
Pretty Stable
Company Equity Multiplier0.921.081.1596
Slightly volatile
Total Debt To Capitalization0.10.09890.0299
Slightly volatile
Debt Equity Ratio0.120.110.0335
Slightly volatile
Quick Ratio10.889.698.8813
Slightly volatile
Net Income Per E B T1.11.151.0163
Slightly volatile
Cash Ratio2.322.445.9676
Very volatile
Free Cash Flow Operating Cash Flow Ratio1.141.171.0899
Pretty Stable
Price To Book Ratio2.933.09829
Slightly volatile
Debt Ratio0.09720.09260.0284
Slightly volatile
Price Fair Value2.933.09829
Slightly volatile

Aura Biosciences Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap490.1 M469.3 M437.5 M
Slightly volatile
Enterprise Value424.7 M454.5 M410.5 M
Very volatile

Aura Fundamental Market Drivers

Aura Upcoming Events

20th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Aura Biosciences Financial Statements

Aura Biosciences stakeholders use historical fundamental indicators, such as Aura Biosciences' revenue or net income, to determine how well the company is positioned to perform in the future. Although Aura Biosciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Aura Biosciences' assets and liabilities are reflected in the revenues and expenses on Aura Biosciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Aura Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue4.4 M3.1 M
Cost Of Revenue1.4 M1.1 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
FSLYFastly Class A
MOBMobilicom Limited American
CMGChipotle Mexican Grill
When determining whether Aura Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aura Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aura Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aura Biosciences Stock:
How To Invest In Aura
Details
Is Aura Stock a good investment?
Details
What is Aura Biosciences' Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Aura Biosciences Correlation against competitors.
For information on how to trade Aura Stock refer to our How to Trade Aura Stock guide.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aura Biosciences. If investors know Aura will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Aura Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(1.91)
Return On Assets
(0.36)
Return On Equity
(0.64)
Understanding Aura Biosciences requires distinguishing between market price and book value, where the latter reflects Aura's accounting equity. The concept of intrinsic value - what Aura Biosciences' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Aura Biosciences' price substantially above or below its fundamental value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Understanding that Aura Biosciences' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Aura Biosciences represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Aura Biosciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY